Showing results (341-350 of 1,042) with videos related to

Sort By:
Pageof 105
Journal of Medicinal Chemistry|May 1, 1991
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosidesK Murakami, T Shirasaka, H Yoshioka, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatineS Kageyama, T Mimoto, Y Murakawa, et al.
Journal of Medicinal Chemistry|May 1, 1991
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugsJ J Barchi, V E Marquez, J S Driscoll, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell inductionS Yokota, T Shirasaka, H Nishikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative studyT Shirasaka, R Yarchoan, M C O'Brien, et al.
Blood|September 25, 2001
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situS Fujii, K Shimizu, T Shimizu, et al.
Early Pregnancy : Biology and Medicine : the Official Journal of the Society for the Investigation of Early Pregnancy|March 1, 1997
Termination of early pregnancy in the rat by a single dose of human menopausal gonadotropinL L Espey, S Stacy, H Hayter, et al.
Cancer|September 15, 1996
Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomasT Nikaido, S F Li, T Shiozawa, et al.
AIDS Research and Human Retroviruses|June 1, 1994
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitroS Kageyama, D T Hoekzema, Y Murakawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselvesM Nishiyama, W Yamamoto, J S Park, et al.
Pageof 105